MOATAZ HAGGAG: Open Payments
NPI 1508966565 · EAST PATCHOGUE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$511 in 19 payments from 7 companies in 2025. Trend: 2023 $62 · 2024 $206 · 2025 $511
Food & beverage: $511
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $207 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $103 |
| E.R. Squibb & Sons, L.L.C. | 3 | $74 |
| Vanda Pharmaceuticals Inc. | 2 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: ARISTADA, CAPLYTA, COBENFY, HETLIOZ, AUSTEDO XR, SPRAVATO, REXULTI.
Industry payments across NY — which companies pay providers there.
